Anthrax Treatment Market
According to Intent Market Research, the Anthrax Treatment Market is expected to grow from USD 210.7 million in 2023 at a CAGR of 8.6% to touch USD 376.6 million by 2030. The Anthrax Treatment Market is dominated by key players such as Emergent BioSolutions, GlaxoSmithKline (GSK), Pfizer Inc., Sanofi, Elusys Therapeutics, Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Johnson & Johnson, CSL Limited, Lonza Group, BioPort Corporation, Altimmune Inc.